Melek Güler-Yüksel

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Rheumatoid Arthritis

Body Composition

Top Venues

Annals of the rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Melek Güler-Yüksel, Martijn Kuijper, Reinhard Bos, Esmeralda Molenaar, Jasper Emmering, Sylvia Eshuis, Adams Human, Floor Reimann, Maarten Boers, Marc-Redwart Kok
Changes in body weight and body composition in patients with active rheumatoid arthritis aged 65+ treated with 2-year low-dose add-on prednisolone in the randomised double-blind placebo-controlled GLORIA trial. RMD open 9 (2) (2023)
Sascha Louise Heckert, Johanna Maria Maassen, S le Cessie, Y P M Goekoop-Ruiterman, Melek Güler-Yüksel, Willem F Lems, Thomas Wj Huizinga, Sytske Anne Bergstra, Cornelia F Allaart
Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohort. Annals of the rheumatic diseases (2023)
Sascha Louise Heckert, Sytske Anne Bergstra, Yvonne P M Goekoop-Ruiterman, Melek Güler-Yüksel, Willem F Lems, Xanthe Marijn Edmée Matthijssen, Maikel van Oosterhout, Thomas Wj Huizinga, Cornelia F Allaart
Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment. RMD open 9 (1) (2023)
Sascha Louise Heckert, Sytske Anne Bergstra, Yvonne P M Goekoop-Ruiterman, Melek Güler-Yüksel, Willem F Lems, Xanthe Marijn Edmée Matthijssen, Maikel van Oosterhout, Thomas Wj Huizinga, Cornelia F Allaart
Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment. RMD open 9 (1) (2023)
Sascha Louise Heckert, Sytske Anne Bergstra, Yvonne P M Goekoop-Ruiterman, Melek Güler-Yüksel, Willem F Lems, Xanthe Marijn Edmée Matthijssen, Maikel van Oosterhout, Thomas Wj Huizinga, Cornelia F Allaart
Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment. RMD open 9 (1) (2023)
Melek Güler-Yüksel, Martijn Kuijper, Reinhard Bos, Esmeralda Molenaar, Jasper Emmering, Sylvia Eshuis, Adams Human, Floor Reimann, Maarten Boers, Marc-Redwart Kok
Changes in body weight and body composition in patients with active rheumatoid arthritis aged 65+ treated with 2-year low-dose add-on prednisolone in the randomised double-blind placebo-controlled GLORIA trial. RMD open 9 (2) (2023)